MPO and neurodegenerative disease: Among these derivatives, compound 28 was found as the most promising compound with excellent in vitro binding profile (Ki σ1 = 0.2 nM, Ki σ2 = 198 nM), high CNS MPO score (5.4) and significant neuritogenesis efficacy, which will be further developed as potential therapeutics for neurodegenerative diseases.